Nathan Slaughter, Chief Investment Strategist of The Daily Paycheck and High-Yield Investing, has developed a long and successful track record over the years by finding profitable investments no matter where they hide. Nathan's previous experience includes a long tenure at AXA/Equitable Advisors, one of the world's largest financial planning firms. He also honed his research skills at Morgan Keegan, where he managed millions in portfolio assets and performed consultative retirement planning services. To reach more investors, Nathan switched gears in 2004 and began writing full-time. He has since published hundreds of articles for a variety of prominent online and print publications. Nathan has interviewed industry insiders like Paul Weisbruch and CEOs like Tom Evans of Bankrate.com, and has been quoted in the Los Angeles Times for his expertise on economic moats. Nathan's educational background includes NASD Series 6, 7, 63, & 65 certifications, as well as a degree in Finance/Investment Management from Sam M. Walton School of Business, where he received a full academic scholarship. When not following the market, Nathan enjoys watching his favorite baseball team, the Cubs, and camping and fishing with his family.
Analyst Articles
It's time for our check-in on companies that are likely to raise dividends in the next month. Read...
Read More
It's time for our check-in on companies that are likely to raise dividends in the next month. Read on for details... Read More
Read More
This is how I find reliable, healthy dividend-paying stocks. And I'll also explain why they are...
Read More
This is how I find reliable, healthy dividend-paying stocks. And I'll also explain why they are essential to building long-term wealth... Read More
Read More
History proves that the best time to buy an asset is often when nobody else wants it. Sometimes it...
Read More
History proves that the best time to buy an asset is often when nobody else wants it. Sometimes it requires patience, but it often pays off big-time... Read More
Read More
There is a well-known way you can stretch your investment to where it can more than provide for any...
Read More
There is a well-known way you can stretch your investment to where it can more than provide for any needs you might have in retirement. Learn more... Read More
Read More
Many industry observers think that the pharma sector will continue producing big deals in the years...
Read More
Many industry observers think that the pharma sector will continue producing big deals in the years to come. And this one could be next... Read More
Read More
It doesn't take a market wiz to understand why this stock is down. But it's also easy to see why...
Read More
It doesn't take a market wiz to understand why this stock is down. But it's also easy to see why patient investors could be rewarded handsomely in the end... Read More
Read More
Like a lot of other stocks that dropped during March, it came roaring back with a vengeance. But...
Read More
Like a lot of other stocks that dropped during March, it came roaring back with a vengeance. But then it drifted back down again despite a booming business. Here's why I don't think the disconnect...
Read More
Don’t be discouraged if you see the market take a breather like we did just recently. Here's why...
Read More
Don’t be discouraged if you see the market take a breather like we did just recently. Here's why it can be a healthy thing.... Read More
Read More
Is there a way to harness the capital appreciation of this group while still pocketing more income?...
Read More
Is there a way to harness the capital appreciation of this group while still pocketing more income? You bet. Read More
Read More
The "big tech" group has absolutely dominated the market leaderboard this year. But don't forget...
Read More
The "big tech" group has absolutely dominated the market leaderboard this year. But don't forget about their small/mid-cap counterparts... Read More
Read More
